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An Ounce of Prevention With a Calcium Score Scan?*
Mario J. Garcia, MD,† Valentin Fuster, MD, PHD†‡
New York, New YorkThe past 2 decades have witnessed great progress in
the treatment of advanced cardiovascular disease.
Mortality of revascularization is close to or below
1% among cardiovascular centers of excellence, time
for reperfusion has been dramatically shortened in
acute coronary syndromes, and a larger segment of
the population has gained access to advanced car-
diovascular care. Yet the burden of cardiovascular
disease has risen over the same period. Every year,
more than 500,000 U.S. residents die from a cardiac
event. Altogether, cardiovascular and cerebrovascu-
lar diseases account for 25% of all deaths in
developed countries (1).
See page 675
Over the past decade, cardiovascular diseases
have moved among the top causes of death in the
adult populations of India and China, the 2 fastest
growing economies in the world. This paradox
suggests that further efforts to improve treatment
will be unlikely to have a great impact on reducing
the socioeconomic burden of cardiovascular disease
in our society. Rather, through effective prevention,
we should aim to reduce the prevalence of athero-
sclerosis. One logical approach is to promote life-
style modification. Some have even suggested the
possibility of implementing primary prevention,
including pharmacologic therapy, throughout the
adult population. At the present, adopting such a
radical concept would be limited by cost, drug side
effects, and limited compliance. Alternatively, many
have proposed screening as a way of identifying
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
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Systems.those subjects at greater risk who would most likely
benefit from primary prevention. Risk stratification
through clinical history, physical examination, and
serum biomarkers has been extensively validated,
and tools such as the Framingham or Reynolds risk
scores have been adopted in clinical practice by
most primary care practitioners. Nevertheless, al-
though these tools identify subsets of the general
population at low or high risk, they leave a signif-
icant number of subjects in an undetermined cate-
gory. As an alternative or complementary tool,
noninvasive atherosclerosis imaging has been pro-
moted on the premise that early detection and
quantification of atherosclerotic plaque burden may
be a better predictor of risk and thus allow cost-
efficient targeting of the population at risk. For such
a screening method to be effective, it must be widely
available, safe, highly reproducible, and inexpensive.
Most experts would agree that the calcium score
scan meets these characteristics (2), explaining its
wide acceptance among the medical community
and the public despite the limited insurance reim-
bursement. Moreover, several large-scale retrospec-
tive and a few prospective studies have unequivo-
cally demonstrated the superior predictive accuracy
of the calcium score for short- and long-term
cardiovascular events.
In epidemiologic studies, coronary artery calcifi-
cation has been associated with a higher risk of
myocardial infarction (MI), even in asymptomatic
patients. Growing evidence suggests that measure-
ment of coronary calcium may be particularly valu-
able in therapy decisions for patients with an
intermediate risk of coronary events. In these pa-
tients with intermediate risk based on clinical fac-
tors, a calcium score300 is significantly associated
with increased rates of MI and coronary death (3).
The value of the calcium score has been recognized
by the American Heart Association (4) and the
National Cholesterol Education Program Adult
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690reatment Panel III (5). In their opinion, asymp-
omatic patients at intermediate risk (10-year risk of
0% to 20% and 2 or more coronary risk factors
ccording to the Framingham criteria) constitute
he group that could benefit the most from changes
n treatment and life-style; thus, in this group, the
uantification of calcium score would be indicated
ost clearly.
In this issue of iJACC, Sarwar et al. (6) report on
meta-analysis of 49 studies to investigate the value
f the absence of coronary calcification (CAC 
) for predicting events in symptomatic and asymp-
omatic patients, obstructive coronary artery disease
n patients undergoing invasive or computed to-
ography coronary angiography, ischemia in pa-
ients undergoing stress myocardial perfusion im-
ging (MPI), and acute coronary syndromes in
atients with acute chest pain.
In this meta-analysis, the authors show consis-
ency in the relative risk ratios (Figs. 1 and 2 of
arwar et al. [6]) for cardiac events in symptom-
tic and asymptomatic subjects with zero and
onzero CAC. Most studies have demonstrated a
emarkably low event rate in asymptomatic pa-
ients with zero CAC. Recently, the MESA
Multi-Ethnic Study of Atherosclerosis) trial
howed that only 8 of 3,409 subjects with zero
AC experienced a major cardiac event at a
edian follow-up of 3.8 years (7). Importantly,
he prevalence of zero CAC in the studied
opulation varied between 30% and 65% accord-
ng to sex and ethnicity. Thus, a significant
egment of the population could be categorized as
aving very low short-term risk. On the other
and, the same study demonstrated that the
dded predictive value for major coronary events
f the calcium score was marginal, increasing the
rea under the curve from 0.79 to 0.83 compared
ith evaluation of risk factors alone. This finding
uggests that the utility of calcium scoring is
imited when applied to the general population.
n earlier study by Greenland (3) demonstrated
hat the clinical value of this test was greatest inal. Reproducibility and accuracy of cor-
prediction in asympt
JAMA 2004;291:210ne limitation of the meta-analysis performed by
arwar et al. (6) is the absence of clinical data to
urther address the incremental prognostic value
f a zero CAC over clinical risk factors.
The meta-analysis performed in symptomatic
ubjects also demonstrated that a zero CAC was
ssociated with a very low event rate in this group.
owever, at least 1 of the studies included (8)
ound that the incidence of obstructive CAD in
hest pain patients with zero CAC is not negligible
7.2%). In these patients, coronary obstruction was
aused by noncalcified atheroma. Clearly, pre-test
robability of disease is an important consideration
hen applying the results of a calcium score for
linical decision making in symptomatic patients.
Finally, many patients with zero CAC have a
ositive MPI but a good prognosis. It is possible
hat many of these cases represent false-positive
PI studies. An important application of calcium
coring thus may be to reduce the incidence of
alse-positive MPI and unnecessary coronary an-
iography.
In summary, the calcium score scan, as supported
y this meta-analysis, is a very promising imaging
iomarker of atherosclerosis. The absence of coro-
ary calcification is associated with a very low
ncidence of cardiac events at 3 to 5 years. Although
he strong prognostic utility of the calcium score is
nquestionable, further studies are needed to eluci-
ate the subject populations in which this test
rovides incremental prognostic utility over clinical
isk assessment and serum biomarkers. Moreover,
uture studies are needed to address whether per-
orming a calcium score leads to treatment modifi-
ations that will result in improved clinical out-
omes and to prove that performing a calcium score
o identify higher-risk populations is superior as a
trategy to providing “an ounce of prevention” to
he population as a whole.
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